These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26346750)

  • 1. Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid.
    Li J; Chen T; Deng F; Wan J; Tang Y; Yuan P; Zhang L
    Int J Nanomedicine; 2015; 10():5475-87. PubMed ID: 26346750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier.
    Lv Y; Li J; Chen H; Bai Y; Zhang L
    Int J Nanomedicine; 2017; 12():4361-4370. PubMed ID: 28652738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
    Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma.
    Xu Y; Wang M; Ning S; Yang Z; Zhou L; Xia X
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
    Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y
    Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
    Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy.
    Qiu M; Wang J; Bai J; Li X; Tian C; Liu Z; Zheng C; Clark AR; Cheng X; Liao X; Wu S; Lee RJ; Zhou X
    Mol Pharm; 2023 Apr; 20(4):1951-1963. PubMed ID: 36952242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid.
    Wang X; Gu X; Wang H; Yang J; Mao S
    Carbohydr Polym; 2018 Sep; 195():170-179. PubMed ID: 29804965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, evaluation, and
    Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of glycyrrhetinic acid modification on preparation and evaluation of quercetin-loaded chitosan-based self-aggregates.
    Du H; Liu M; Yang X; Zhai G
    J Colloid Interface Sci; 2015 Dec; 460():87-96. PubMed ID: 26319324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
    Zhang L; Yao J; Zhou J; Wang T; Zhang Q
    Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers.
    Chu Y; Li D; Luo YF; He XJ; Jiang MY
    Molecules; 2014 Feb; 19(2):2445-57. PubMed ID: 24566313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes.
    Sun Y; Dai C; Yin M; Lu J; Hu H; Chen D
    Int J Nanomedicine; 2018; 13():1621-1632. PubMed ID: 29588589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective co-delivery of doxorubicin and curcumin using a glycyrrhetinic acid-modified chitosan-cystamine-poly(ε-caprolactone) copolymer micelle for combination cancer chemotherapy.
    Yan T; Li D; Li J; Cheng F; Cheng J; Huang Y; He J
    Colloids Surf B Biointerfaces; 2016 Sep; 145():526-538. PubMed ID: 27281238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembled nanoparticles of glycyrrhetic acid-modified pullulan as a novel carrier of curcumin.
    Yuan R; Zheng F; Zhong S; Tao X; Zhang Y; Gao F; Yao F; Chen J; Chen Y; Shi G
    Molecules; 2014 Aug; 19(9):13305-18. PubMed ID: 25170951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
    Du H; Liu M; Yu A; Ji J; Zhai G
    Int J Pharm; 2017 May; 523(1):427-438. PubMed ID: 28359815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced targeted delivery of adenine to hepatocellular carcinoma using glycyrrhetinic acid-functionalized nanoparticles in vivo and in vitro.
    Wu F; Xue H; Li X; Diao W; Jiang B; Wang W; Yu W; Bai J; Wang Y; Lian B; Feng W; Sun T; Qu M; Zhao C; Wang Y; Wu J; Gao Z
    Biomed Pharmacother; 2020 Nov; 131():110682. PubMed ID: 32947204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication and evaluation of nanoparticle-assembled BSA microparticles for enhanced liver delivery of glycyrrhetinic acid.
    Wang W; Lei Y; Sui H; Zhang W; Zhu R; Feng J; Wang H
    Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):740-747. PubMed ID: 27267996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
    Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.